59 Epizód

  1. The state of psychedelics: Dr. Rachel Yehuda and Zach Haigney (live recording at Soho House)

    Közzétéve: 2022. 06. 05.
  2. Empowering the next wave of psychedelic therapists: Journey Clinical

    Közzétéve: 2022. 05. 23.
  3. Osmind and the future of electronic health records in psychedelic medicine

    Közzétéve: 2022. 04. 18.
  4. Palo Santo on investing in 2nd gen psychedelics and public markets

    Közzétéve: 2022. 03. 21.
  5. Designing psychedelic mindstates, with Mindstate Design Labs

    Közzétéve: 2022. 02. 10.
  6. PsyMed Ventures, our venture fund to invest in psychedelic medicine & mental health tech

    Közzétéve: 2022. 01. 10.
  7. MAPS PBC, rethinking the pharma business model and MDMA-assisted therapy

    Közzétéve: 2021. 11. 24.
  8. On transformational ketamine therapy and running an integrative psychedelic clinic

    Közzétéve: 2021. 10. 28.
  9. The new frontiers of DMT therapies

    Közzétéve: 2021. 10. 06.
  10. Scaling Psilocybin Therapy: Compass Pathways' Lars Wilde

    Közzétéve: 2021. 08. 13.
  11. Analyzing the atai Life Sciences IPO

    Közzétéve: 2021. 06. 10.
  12. A 30 year journey towards ibogaine approval: Deborah Mash, CEO of DemeRx

    Közzétéve: 2021. 05. 04.
  13. Clinical trials, media, reciprocity, open science: Founder of The Trip Report, Zach Haigney

    Közzétéve: 2021. 03. 16.
  14. How to (legally) make psychedelic medicine: CEO of Psygen, Danny Motyka

    Közzétéve: 2021. 02. 24.
  15. From serving medicine to company founder: NANA founder Flor Bollini

    Közzétéve: 2021. 01. 05.
  16. Helping psychedelic practitioners through software: Maya Health CEO David Champion

    Közzétéve: 2020. 10. 19.
  17. How to invest in psychedelic companies: Vine Ventures' Founder Ryan Zurrer

    Közzétéve: 2020. 09. 17.
  18. Building a psychedelic media company: DoubleBlind's Shelby Hartman and Madison Margolin

    Közzétéve: 2020. 08. 13.
  19. Dylan Beynon: ketamine-assisted therapy for anxiety and depression

    Közzétéve: 2020. 06. 21.

3 / 3

Business Trip tells the story of businesses at the frontier of mental health and brain health. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more. 

Visit the podcast's native language site